Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02854371Phase 4Completed
A Phase 4 trial of gadoxetate disodium in chronic liver disease (CLD), Cirrhosis, sponsored by Seoul National University Hospital. Started Aug 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02854371.